retatrutide glp 1 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide Peptide: Triple Agonist Mechanism,

PT-141 Investigations into Cavernous Tissues Studies have also explored PT-141 within the context of cavernous tissue physiology

In January 2024, the FDA announced it was evaluation reports of hair loss and suicidal thoughts in patients taking Ozempic, Mounjaro, or Wegovy

Cell Cycle 15 , 7283 (2016)

investigated the effects of KRH102053 (2-amino-4-methylsulphanyl-butylic acid-4-methoxy-6-(4-methoxy-benzylamino)-2, 2-dimethyl-chroman-3-yl ester), a novel small-molecule activator of PHD2, in human HOS osteosarcoma, rat PC12 phaeochromocytoma and human HepG2 hepatoma cells

In this post, well dive into what makes N-Acetyl L-Carnitine HCL so remarkable, its benefits, and why its a cornerstone ingredient in our Brain Support Complex at 2nd Springs